Agenda

April 18, 2012
Time	Presentation
7:15–8:00 am	Registration & Networking Breakfast
8:00–8:30 am	NY Biotech Initiative Ron Cohen, President & CEO, Acorda Therapeutics; Mikael Dolsten, President Worldwide R&D Pfizer; Marc Tessier Lavigne, President, Rockefeller University Moderator: Jean-Francois Formela, Partner, Atlas Ventures
8:30–8:45 am	Partnership Between FDA & Drug Development Janet Woodcock, Director, Drug Evaluation & Research, FDA
8:45–9:15 am	Biotechnology Industry Organization (BIO) Initiatives Josh Boger, former CEO Vertex; Jim Greenwood, President and CEO, BIO
9:15–10:00 am	Networking
10:00–2:00 pm	Three Concurrent Workshops (see full agendas below) Orphan Drug Summit (Main ballroom) Cancer Drug Development Summit (Bangkok room) Fertility Summit (Beijing room)
2:00–3:00 pm	Wine and cheese

Three concurrent agendas in adjacent rooms from 10:00 – 2:00pm.

Orphan Drug Summit
Time	Presentation
10:00–10:45 am	Orphan Drug Development and Regulation: Abbie Celniker, Eleven Biotherapeutics; Nick Leschly, Bluebird Bio; Arthur Tzianabos, Shire; Tim Cote, NORD Moderator: Neil Kirby, Edimer Pharmaceuticals
10:45–11:30 am	Orphan Drug Company Strategies: Matthew Emmens, Vertex; JC Gutierrez-Ramos, Pfizer; Catherine Sohn, Sohn Health Strategies; David Meeker, Genzyme Moderator: Mike Gilman, Stromedix
11:30–12:20 pm	Networking Lunch
12:20–1:05 pm	Business Development and Role of VC in Orphan Drug Development: Matt Patterson, OrbiMed Advisors; Phil Reilly, Third Rock Ventures; Alan Walts, Genzyme Ventures Moderator: Michelle Dipp, Longwood Fund
1:05–1:15 pm	Patient Associations: Stu Peltz, PTC Therapeutics; Peter Saltonstall, NORD
1:15–2:00 pm	Commercial Strategies: Chris Adams, Formerly FoldRx/Pfizer; David Hallal, Alexion Pharmaceuticals; Barry Frankel, Frankel Group Moderator: Barbara Deptula, Shire
2:00–3:00 pm	Wine and Cheese

Fertility Summit
Time	Presentation
10:00–10:25 am	Bioenergetics in IVF: David Sable, Special Situations Life Sciences Fund
10:25–10:35 am	The Role of Mitochondria in Fertility: Robert Casper, University of Toronto
10:35–10:45 am	Type II Diabetes and Fertility
10:35–10:45 am	Type II Diabetes and Fertility
10:45–11:30 am	New Advances in Fertility Treatment: Alan Penzias, Harvard Medical School, BIDMC, Boston IVF; Mitchell Rosen, University of California, San Francisco
11:30–12:30 pm	Networking Lunch
12:30–1:15 pm	Fertility and Aging: Jonathan Tilly, MGH & Harvard Medical School; David Sinclair, Harvard Medical School Moderator: Scott Chappel, OvaScience
1:15–2:00 pm	Patient Advocacy: Barbara Collura, Resolve: The National Infertility Association Moderator: Michelle Dipp, OvaScience
2:00–3:00 pm	Wine and Cheese